TY - JOUR
T1 - Characterization of a human homologue of proteolysis-inducing factor and its role in cancer cachexia
AU - Monitto, Constance L.
AU - Dong, Seung Myung
AU - Jen, Jin
AU - Sidransky, David
PY - 2004/9/1
Y1 - 2004/9/1
N2 - Cachexia is an important cause of secondary morbidity and mortality in patients with cancer. Previous studies have suggested that cancer-associated cachexia may be due in part to tumor-specific production and secretion of a glycosylated peptide, proteolysis-inducing factor, originally identified in a murine cancer cachexia model. We report here the cloning of a human cDNA that generates a peptide having high-sequence homology to this proteolysis-inducing factor. Constitutive expression of human proteolysis-inducing factor is low or absent in most normal human tissues but appears to be elevated in some human tumors. Stable forced expression of human proteolysis-inducing factor in multiple murine and human cell lines results in a secreted protein, but no glycosylation of the protein is detected. In addition, tumor xenografts engineered to overexpress human proteolysis-inducing factor protein do not induce cachexia in vivo. These findings raise important questions as to potential cross-species differences in protein sequence and processing of murine proteolysis-inducing factor and human proteolysis-inducing factor, as well as the nature of the relationship between human proteolysis-inducing factor and the development of cancer cachexia.
AB - Cachexia is an important cause of secondary morbidity and mortality in patients with cancer. Previous studies have suggested that cancer-associated cachexia may be due in part to tumor-specific production and secretion of a glycosylated peptide, proteolysis-inducing factor, originally identified in a murine cancer cachexia model. We report here the cloning of a human cDNA that generates a peptide having high-sequence homology to this proteolysis-inducing factor. Constitutive expression of human proteolysis-inducing factor is low or absent in most normal human tissues but appears to be elevated in some human tumors. Stable forced expression of human proteolysis-inducing factor in multiple murine and human cell lines results in a secreted protein, but no glycosylation of the protein is detected. In addition, tumor xenografts engineered to overexpress human proteolysis-inducing factor protein do not induce cachexia in vivo. These findings raise important questions as to potential cross-species differences in protein sequence and processing of murine proteolysis-inducing factor and human proteolysis-inducing factor, as well as the nature of the relationship between human proteolysis-inducing factor and the development of cancer cachexia.
UR - http://www.scopus.com/inward/record.url?scp=4444384629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4444384629&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-04-0435
DO - 10.1158/1078-0432.CCR-04-0435
M3 - Article
C2 - 15355918
AN - SCOPUS:4444384629
SN - 1078-0432
VL - 10
SP - 5862
EP - 5869
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 17
ER -